Effect of Preoperative Exercise on the Prevention of Secondary Lymphedema in Breast Cancer Patients

NCT ID: NCT06421285

Last Updated: 2025-06-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-01-10

Study Completion Date

2025-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Research purpose: Lymphedema is a very common complication in breast cancer patients. However, since there is currently no curable treatment, it is important to prevent and reduce the severity of lymphedema. The purpose of this study is to evaluate whether preoperative exercise is effective in preventing lymphedema after surgery. For secondary outcome, the preventive effects of exercise on other upper extremity dysfunctions (eg. pectoralis tightness, Axillary web syndrome, Adhesive capsulitis), which are common in breast cancer patients, were assessed.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Study subjects:

* Patients aged 20 or older who were first diagnosed with breast cancer
* Patients scheduled to undergo neoadjuvant chemotherapy before surgery Study design: Prospective randomized controlled comparative clinical study
* Intervention is performed for at least 3 months during the neoadjuvant chemotherapy period before surgery.
* Treatment group: Individually tailored exercise consisting of aerobic, strength, and flexibility exercises is prescribed, self-exercise compliance monitoring through an application, and diet management education through nutritional counseling.
* Control group: One session of flexibility exercise training, diet management education through nutritional counseling

Result variable:

* Primary outcome variable:

1\) Incidence and severity of postoperative lymphedema: bilateral upper limb volume, ICG lymphography
* Secondary outcome variables:

1. Clinical information: Demographic, disease and treatment-related data
2. Physical-related: height/weight/waist circumference measurement, body composition test, physical examination (axillary membrane evaluation)
3. Upper extremity function (shortening of the pectoralis major muscle, adhesive capsulitis): evaluation of shoulder range of motion, upper extremity muscle strength/grip strength
4. Quality of life assessment: European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30(EORTC QLQ-C30), European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Breast cancer module 23(EORTC QLQ-BR23)

Assessment Schedule:

* Initial treatment and evaluation: Immediately after breast cancer diagnosis
* Follow-up evaluation: Immediately after completion of exercise intervention (preoperatively), and at 1, 3, and 6 months postoperatively.

Number of study subjects:

* This study will be conducted as a preliminary study for future research, and will be conducted on a total of 60 patients (30 in the experimental group and 30 in the control group) with an allocation ratio between groups of 1:1.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Breast Neoplasms

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

* Intervention group
* Control group
Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

SINGLE

Participants
* Patients aged 20 or older and younger than 80 years old who were first diagnosed with breast cancer
* Patients scheduled to undergo neoadjuvant chemotherapy before surgery

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention group

Individually tailored exercise consisting of aerobic, strength, and flexibility exercises is prescribed, self-exercise compliance monitoring through an application, and diet management education through nutritional counseling.

Group Type EXPERIMENTAL

Aerobic exercise, Strength training, Flexibility exercise

Intervention Type BEHAVIORAL

Aerobic exercise: 30-40 minutes/time, 3-5 times a week, intensity of 4-6 points on the Rating of Perceived Exertion(RPE) 10-point scale(A simple conversation is possible during exercise, but the intensity is such that you feel out of breath) Strength training: 2-3 times a week, 3 sets of 10 repetitions per movement

* Upper extremities: Biceps brachii, triceps brachii, deltoid, pectoralis muscle exercise
* Lower extremities: gluteus maximus, hamstrings, quadriceps exercise Flexibility exercise: Stretching and mobility exercises reflecting post-surgery rehabilitation

Control group

One session of flexibility exercise education, diet management education through nutritional counseling

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Aerobic exercise, Strength training, Flexibility exercise

Aerobic exercise: 30-40 minutes/time, 3-5 times a week, intensity of 4-6 points on the Rating of Perceived Exertion(RPE) 10-point scale(A simple conversation is possible during exercise, but the intensity is such that you feel out of breath) Strength training: 2-3 times a week, 3 sets of 10 repetitions per movement

* Upper extremities: Biceps brachii, triceps brachii, deltoid, pectoralis muscle exercise
* Lower extremities: gluteus maximus, hamstrings, quadriceps exercise Flexibility exercise: Stretching and mobility exercises reflecting post-surgery rehabilitation

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients aged 20 or older and younger than 80 who were first diagnosed with breast cancer
* Patients scheduled for surgery and starting neoadjuvant chemotherapy before surgery

Exclusion Criteria

* Patients with medical contraindications to exercise intervention or pain or musculoskeletal conditions that may limit active exercise intervention
Minimum Eligible Age

20 Years

Maximum Eligible Age

80 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Asan Medical Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Jae Yong Jeon, MD

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jaeyong Jeon

Role: PRINCIPAL_INVESTIGATOR

Asan Medical Center

Heejeong Kim

Role: STUDY_CHAIR

Asan Medical Center

Seungwoo Cha

Role: STUDY_CHAIR

Asan Medical Center

Chul Jung

Role: STUDY_CHAIR

Asan Medical Center

Hwayeong Cheon

Role: STUDY_CHAIR

Asan Medical Center

Junghwa Do

Role: STUDY_CHAIR

Asan Medical Center

Woojin Jeong

Role: STUDY_CHAIR

Asan Medical Center

Doyoung Kim

Role: STUDY_CHAIR

Asan Medical Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Seoul Asan Medical Center

Seoul, Seoul Special City, South Korea

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

South Korea

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Jaeyong Jeon

Role: CONTACT

+82-2-3010-3791

Seungwoo Cha

Role: CONTACT

+82-2-3010-3799

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Jaeyong Jeon

Role: primary

+82-10-9970-3791

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2024-0255

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.